About Index Trending news
Analyze
Pricing
Interface Biologics

Interface Biologics

Interface Biologics

Develops transformative biomedical polymer technology to improve safety of med device. Focused on anti-thrombogenic additives and combo drug delivery devices.

Elsewhere

Alexa global traffic share

Twitter followers

08 Dec 2011
$1,000,000
Venture capital
11 Jan 2011
$7,000,000
Venture capital (Series B)
01 Jan 2010
$19,000,000
Venture capital (Series A)
09 Dec 2008
$5,000,000
Venture capital
BDC Capital, Covington Capital